• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Strategies to Reduce Antipsychotic-Induced Hyperprolactinemia
Research Update

Strategies to Reduce Antipsychotic-Induced Hyperprolactinemia

January 1, 2025
Sarah Azarchi, MD
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Sarah Azarchi, MD. Dr. Azarchi has no financial relationships with companies related to this material.

Getting your Trinity Audio player ready...

REVIEW OF: Zhe L et al, Transl Psychiatry2022;12(1):267

STUDY TYPE: Systemic review and network meta-analysis 

Many patients on antipsychotic drugs—up to 70%—face a common side effect: increased levels of prolactin. This condition, which is typically seen when levels exceed 20 ng/mL in patients who are not pregnant, can lead to issues like reduced libido, breast enlargement, and galactorrhea. Men may experience erectile dysfunction, and postmenopausal women may see a decrease in bone density.

A comprehensive review involving 31 randomized controlled trials, with around 2,000 participants in total, investigated ways to lower elevated prolactin levels in patients who were taking antipsychotic medications. The study explored various methods: switching antipsychotic drugs, supplementing with vitamin B6 (200–1200 mg), using dopamine agonists such as bromocriptine and cabergoline, and even an herbal remedy (peony-glycyrrhiza decoction). Researchers also investigated the effectiveness of aripiprazole, a drug known from previous studies to lower prolactin levels, either when added to a patient’s regimen or as a replacement for their current medication.

The findings varied based on patients’ initial prolactin levels. For those whose starting levels were very high (above 100 ng/mL), adding a low dose of aripiprazole (5 mg daily) was the only method that significantly cut prolactin levels. For levels of 50–100 ng/mL, either switching to aripiprazole, adding aripiprazole as an adjunct (in doses of 5–10+ mg daily), or incorporating vitamin B6 significantly helped. When prolactin levels were below 50 ng/mL, none of the strategies made a significant difference. The study didn’t delve into whether these reductions in prolactin also eased the related symptoms or affected psychotic symptoms, nor did it consider differences between genders.

CARLAT TAKE

When prescribing antipsychotics, it’s crucial to keep an eye on your patients’ prolactin levels. For patients with prolactin levels over 100 ng/mL, adding just 5 mg of aripiprazole can be beneficial. For those with prolactin levels of 50–100 ng/mL, adding or switching to aripiprazole are both viable alternatives, as is simply adding high-dose vitamin B6. This study did not investigate reducing the offending antipsychotic, which may also be helpful.

General Psychiatry
KEYWORDS antipsychotics aripiprazole prolactin
    Sarah Azarchi, MD

    Estrogen in Schizophrenia

    More from this author
    www.thecarlatreport.com
    Issue Date: January 1, 2025
    SUBSCRIBE NOW
    Table Of Contents
    Learning Objectives, Adult ADHD, TCPR, January 2025
    How to Diagnose Borderline Personality Disorder
    ADHD: Beyond Stimulants
    Immediate vs Extended-Release Quetiapine for Schizophrenia
    Strategies to Reduce Antipsychotic-Induced Hyperprolactinemia
    Cariprazine Augmentation for MDD
    CME Post-Test, Adult ADHD, TCPR, January 2025
    DOWNLOAD NOW
    Featured Book
    • MFB7e_Print_App_Access.png

      Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book

      The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2622607431.jpg
      General Psychiatry

      Should You Test MTHFR?

      MTHFR is a...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.